These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 21142405

  • 1. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
    Colović M, Suvajdzic N, Colović N, Tomin D, Vidović A, Palibrk V.
    Platelets; 2011; 22(2):153-6. PubMed ID: 21142405
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura.
    Hou M, Peng J, Shi Y, Zhang C, Qin P, Zhao C, Ji X, Wang X, Zhang M.
    Eur J Haematol; 2003 Jun; 70(6):353-7. PubMed ID: 12756016
    [Abstract] [Full Text] [Related]

  • 3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C.
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil therapy for severe immune thrombocytopenia.
    Taylor A, Neave L, Solanki S, Westwood JP, Terrinonive I, McGuckin S, Kothari J, Cooper N, Stasi R, Scully M.
    Br J Haematol; 2015 Nov; 171(4):625-30. PubMed ID: 26250874
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P, Busto MJ, Díez JL, Cabrera R, Regidor C, Forés R, Sanjuán I, Briz M, Fernández MN.
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [Abstract] [Full Text] [Related]

  • 6. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C, Castaman G, Rodeghiero F.
    Haematologica; 1993 Jun; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 9. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R, Stipa E, Masi M, Cecconi M, Scimò MT, Oliva F, Sciarra A, Perrotti AP, Adomo G, Amadori S.
    Am J Med; 1995 May; 98(5):436-42. PubMed ID: 7733121
    [Abstract] [Full Text] [Related]

  • 10. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
    Arnold DM, Nazi I, Santos A, Chan H, Heddle NM, Warkentin TE, Kelton JG.
    Blood; 2010 Jan 07; 115(1):29-31. PubMed ID: 19897578
    [Abstract] [Full Text] [Related]

  • 11. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
    Ann Hematol; 2002 Aug 07; 81(8):436-40. PubMed ID: 12224000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM.
    Platelets; 2008 Nov 07; 19(7):489-95. PubMed ID: 18979360
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan 07; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.